The Worldwide Digital Diabetes Management Industry is Expected to Reach $25.5 Billion by 2027 - GlobeNewswire

Overview

October 28, 2022 07:18 ET | Source: Research and Markets Dublin, IRELAND Dublin, Oct. 28, 2022 (GLOBE NEWSWIRE) - The "Digital Diabetes Management Market by Product (Device (Smart Glucometer, CGM, Insulin Patch Pump), Diabetes Aps, Service, Data Management Software), Device Type (Handheld & Wearables), End User (Hospitals & Self/home healthcare) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.The global digital diabetes management market is projected to reach USD 25.5 billion by 2027 from an estimated USD 14.3 billion in 2022, at a CAGR of 12.2% during the forecast period.Smart glucose meters segment accounted for the largest share in the Digital Diabetes Management marketThe devices segment is categorized into smart glucose meters, CGM systems, smart insulin pens, and smart insulin pumps/closed-lop systems & smart insulin patches.

Key Information

In 2021, the smart glucose meters segment accounted for a share of 25.2% of the digital diabetes management devices market.The growth of this segment is mainly atributed to the easy handling of smart glucose meters, as wel as their benefits in the early detection of hypo and hyperglycemic diabetes. Technological inovations, such as al-in-one glucometers with analysis capabilities, Bluetoth-enabled glucometers, and portable pocket-size glucometers are some of the other factors driving the growth of this market segment.Wearable devices segment to grow at the highest CAGR during the forecast periodVarious devices considered in the digital diabetes management devices market are categorized into handheld devices and wearable devices.

Summary

Wearable devices accounted for the largest share of 60.3% of the digital diabetes management devices market in 2021.This segment is estimated to grow at the highest CAGR of 13.2% during the forecast period. The increasing number of regulatory aprovals for wearables, technological advancements, and the growing adoption of smart insulin

Frequently Asked Questions

Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.

Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.

Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.

Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.

Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.

Share this article